Biocon Q2 FY27 results and investor call scheduled for November 4

Results View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹328.80

prior close

₹329.80

announcement price

After-mkt

timing

Nifty Midcap 150market+0.9%+0.2% vs market

Pharmaceuticals peers, median of 173sector+2.0%-0.9% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Midcap 150 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.2

15m

+0.5

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1+0.9+0.2+2.0-0.9

Next day

+6.0pendingpending+2.6+3.4

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon will hold a Board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. An investor earnings call is set for 4:00 pm IST the same day. Trading in Biocon securities is closed from October 1 to November 6 and reopens November 7.

Likely market impact

No financial figures were provided. Shareholders should await the November 4 results, which could move the stock after trading resumes.